HealthEquity, Inc. (NASDAQ:HQY) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been assigned an average recommendation of “Moderate Buy” from the fourteen brokerages that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $110.5714.

Several analysts have recently commented on HQY shares. Wall Street Zen upgraded HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday, June 6th. Barrington Research reiterated an “outperform” rating and set a $110.00 price target on shares of HealthEquity in a research report on Friday, May 22nd. Citizens Jmp increased their price objective on shares of HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a report on Monday, June 1st. Weiss Ratings raised shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on shares of HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a research note on Thursday, March 19th.

Insider Transactions at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 7,500 shares of the stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the transaction, the executive vice president owned 91,141 shares of the company’s stock, valued at approximately $8,202,690. This represents a 7.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the stock in a transaction that occurred on Friday, May 29th. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the sale, the executive vice president owned 59,113 shares in the company, valued at $5,615,735. This represents a 5.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 13,081 shares of company stock worth $1,193,000 in the last three months. Insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the business. Acumen Wealth Advisors LLC bought a new stake in shares of HealthEquity during the 4th quarter worth approximately $27,000. Caitong International Asset Management Co. Ltd raised its position in shares of HealthEquity by 1,723.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after purchasing an additional 293 shares during the period. Aster Capital Management DIFC Ltd acquired a new stake in HealthEquity during the fourth quarter worth approximately $28,000. Leonteq Securities AG lifted its position in HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after acquiring an additional 235 shares during the last quarter. Finally, Axiom Investment Management LLC bought a new stake in shares of HealthEquity during the first quarter worth approximately $33,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

NASDAQ:HQY opened at $85.21 on Friday. HealthEquity has a 1 year low of $72.76 and a 1 year high of $106.60. The firm has a 50 day moving average of $84.85 and a 200-day moving average of $85.22. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $7.12 billion, a P/E ratio of 31.91, a price-to-earnings-growth ratio of 1.45 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. HealthEquity’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, sell-side analysts anticipate that HealthEquity will post 3.92 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.